Skip to content

Homoeopathic intervention in benign breastlumps

A Multi-centre single blind randomized placebo controlled trial to evaluate the efficacy of individualized Homoeopathic intervention in breast fibroadenoma

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2013/11/004144
Enrollment
200
Registered
2013-11-14
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Breast fibroadenoma

Interventions

Intervention1: Individualised homoeopathic medicine.: Medicine shall be given in 6c, 30c, 200c or 1M potency to be taken orally as per the prescribing totality of the case.Duration of intervention wil

Sponsors

Central Council of Research in Homoeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: i. Female aged 18 to 35 years ii. Diagnosis of breast fibroadenoma based on: Clinical examination, Ultrasound image and confirmation by FNAC iii. Fibroadenoma size between 1 cm and 5 cm at its largest dimension (measured by sonomammography) iv. The tumors may be single, multiple and/or bilateral v. Only one fibroadenoma per quadrant vi. Written Informed consent from the patient

Exclusion criteria

Exclusion criteria: i. Patient pregnant or lactating ii. Complex fibroadenomas and giant (juvenile) fibroadenoma of the breast iii. Tumors that have hypercellularity suggestive of phylloides, atypia, or equivocal pathology report (e.g. discordance between sonomamography and microscopic results). iv. Fibrocystic disease of the breast v. Tubular adenoma of the breast vi. Hamartoma of the breast vii. Family history of breast cancer or history of laser or radiation therapy to the target breast viii. Cases with other systemic diseases like cardiovascular, endocrinal diseases or Systemic illnesses or on other treatment therapies

Design outcomes

Primary

MeasureTime frame
Reduction/ resolution of breast fibroadenoma through sonomammographyTimepoint: Baseline, 3rd month and 6th month

Secondary

MeasureTime frame
NoneTimepoint: None

Countries

India

Contacts

Public ContactDr Chetna Deep Lamba

Central Council of Research in Homoeopathy

oberai.praveen@gmail.com011-28525749

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 9, 2026